Blis Technologies Limited was formed to commercialise probiotic bacteria with bacteriocin activity.
Professor John Tagg of the Microbiology department at the University of Otago gathered and extensively catalogued a collection of more than 2000 of these bacteria over a period of more than 30 years.
Blis Technologies acquired the rights to this unique collection of bacteria from the University of Otago in New Zealand and in July 2001, the company was listed on the New Zealand Stock Exchange. In the time since its listing on the New Zealand Stock Exchange, the company has developed consumer products for throat health, halitosis (bad breath), and probiotic support for the body.
There are no related reviews.
There are no related blog articles.